A new classification option for NSAID hypersensitivity: Kalyoncu classification
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, vol.50, no.6, pp.122-127, 2022 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 50 Issue: 6
- Publication Date: 2022
- Doi Number: 10.15586/aei.v50i6.693
- Journal Name: ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, DIALNET
- Page Numbers: pp.122-127
- Keywords: drug hypersensitivity, European Network for Drug Allergy, Kalyoncu classification, nonsteroidal anti-inflammatory drugs, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, EXACERBATED RESPIRATORY-DISEASE, PRACTICAL APPROACH, ANAPHYLAXIS, PREVALENCE, PATTERNS, ASTHMA, MANAGEMENT
- Open Archive Collection: AVESIS Open Access Collection
- Hacettepe University Affiliated: Yes
Abstract
Background: The European Network for Drug Allergy (ENDA) proposed a consensus document for hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) in 2011. A subgroup of patients with NSAIDs-exacerbated respiratory disease (NERD) develop urticaria/ angioedema type reactions in response to NSAIDs. The Kalyoncu classification might be a novel option to classify patients with NSAID hypersensitivity (NH). In this study, we compare the ENDA and the Kalyoncu classifications.